Zobrazeno 1 - 10
of 94
pro vyhledávání: '"M Roelandts"'
Publikováno v:
Revue Medicale de Bruxelles. 43:127-134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::479e31763f56093d8e9d30fc87682ee8
https://doi.org/10.30637/2022.20-098
https://doi.org/10.30637/2022.20-098
Autor:
D, Bron, R, Dewind, B, Cantinieaux, E, Woff, M, Roelandts, C, Moerman, M, Lemort, P, Heimann, V, De Wilde, N, Meuleman, M, Maerevoet
Publikováno v:
Revue medicale de Bruxelles. 36(4)
Malignant lymphoma and other lymphoproliferative disorders represent a group of malignant hemopathies where immunotherapy has allowed spectacular progresses over the last ten years. The recent W.H.O. classification, based upon tumor immunology, and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7be1eba8d1a76844a6471417abae8f2
https://pubmed.ncbi.nlm.nih.gov/26591307
https://pubmed.ncbi.nlm.nih.gov/26591307
Autor:
S, Holbrechts, M, Roelandts
Publikováno v:
Revue medicale de Bruxelles. 35(3)
These updated clinical practice guidelines on the treatment of small cell lung cancer (SCLC) limited disease formulated by the ELCWP aim to answer the following questions: 1) What is the definition of limited disease? 2) Is thoracic irradiation neede
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cfae72c91e5f9421465c66b05310401d
https://pubmed.ncbi.nlm.nih.gov/25102582
https://pubmed.ncbi.nlm.nih.gov/25102582
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 18(5-6)
This article reviews and describes the progress made in the therapeutic management of patients suffering from a lung cancer, outlining the major improvements made and suggesting some perspectives for the future.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab909f4f5495abaa40fda18de6dccc21
https://pubmed.ncbi.nlm.nih.gov/25195118
https://pubmed.ncbi.nlm.nih.gov/25195118
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 18(5-6)
This review updates the radiotherapy indications for non-malignant diseases, except those treated by radiosurgery. Since the last 2005 review, there have been no major changes in the indications: the prevention of heteropic bone formation and keloids
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aae38578f3fbb273224f6a7e878324f8
https://pubmed.ncbi.nlm.nih.gov/25216586
https://pubmed.ncbi.nlm.nih.gov/25216586
Autor:
R, Firescu, K, Muylle, M, Roelandts, A, de Wind, C, Moerman, M, Lemort, A, Kentos, N, Meuleman, D, Bron
Publikováno v:
Revue medicale de Bruxelles. 32(2)
Non hodgkin's lymphomas are a group of haematological malignancies in which spectacular progress has been made over the last ten years thanks to immunotherapy. Furthermore, the new WHO classification, based upon tumour immunology, the degree of tumou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7d2b61ea0450968070ccba27e382788
https://pubmed.ncbi.nlm.nih.gov/21688592
https://pubmed.ncbi.nlm.nih.gov/21688592
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 15(6-7)
Traditionally, the target volumes of curative-intent radiotherapy for non-small cell lung cancer include all uninvolved mediastinal nodes. However, an improvement in tumour control requires an increase of the total dose to the macroscopic target volu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4472d20178ebe8042026c7a30af606b0
https://pubmed.ncbi.nlm.nih.gov/21873096
https://pubmed.ncbi.nlm.nih.gov/21873096
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 15(6-7)
Postoperative radiotherapy remains controversial in non-small cell lung cancer. The conclusions of several meta-analysis are still questioned, partly because of flaws in the randomized trials taken into account. The technological improvements of mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14041603d19f7a59e7995f1ea9a5c673
https://pubmed.ncbi.nlm.nih.gov/21820931
https://pubmed.ncbi.nlm.nih.gov/21820931
Autor:
P, Van Houtte, M, Roelandts
Publikováno v:
Revue des maladies respiratoires. 25(8 Pt 2)
The most important progress made during the last years in the management of small cell lung cancer is certainly the recognition of the impact of chest radiotherapy for limited disease and prophylactic cranial irradiation (PCI) for patients in complet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de9ffdc11f58b22b925f074aa3b1916b
https://pubmed.ncbi.nlm.nih.gov/18971842
https://pubmed.ncbi.nlm.nih.gov/18971842
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 9(6-7)
The authors present an update version of the indications for radiotherapy in the management of benign diseases. This is based on available randomized trials and recent international meetings. Validated indications remain the prevention of resected he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::570fc3f00abcb144baa606ad5615b1c7
https://pubmed.ncbi.nlm.nih.gov/16219478
https://pubmed.ncbi.nlm.nih.gov/16219478